Epstein Secrets

and future affiliates, related entities (including without limitation 1 EFTA_R1_00430226 EFTA01962678 any other entities owned or controlled by William H. Gates III), predecessors, successors and assigns, the Bill & Melinda Gates Foundation, and their present and former owners, officers, directors, stockholders

request to purchase from [bgC3] (a) up to 30% of [bgC3]'s equity interests in Foundation Medicine and (b) up to 30% of [bgC3]'s equity interests in ResearchGate, in each case in cash at a price per share or unit equivalent to the original price per share or unit paid by [bgC3] (collectively, the "Investment

CONFIDENTIAL DRAFT FOR PURPOSES OF SETTLEMENT DISCUSSIONS ONLY September 3, 2013 William H. Gates Dear Bill: RE: Letter of Agreement Regarding Purchase of Partnership Interest This letter sets forth the agreement by and between you, William H.

t (including all dividends, payments, distributions, securities and other items of value at any time previously or hereafter distributed or paid by ResearchGate in - 63 - EFTA_R1_00438149 EFTA01961337 3. respect of such investment) as of the date of such Investment Entity Payment Demand, less (b) Ten Mi

tter of Agreement Regarding Purchase of Partnership Interest Effective September 3, 2013, this letter sets forth the "Agreement" by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partners

uch investment, together with any and all dividends, payments, distributions, securities or other items of value at any time distributed or paid by ResearchGate to the Gates Purchaser in respect of such investment shall be referred to herein as the "ResearchGate Investment"). At any time and from time to t

r party to seek to limit disclosure to the fullest extent allowed by law or equity. AGREED TO AND ACCEPTED Boris Nikolic AGREED TO AND ACCEPTED William H. Gates - 9 - EFTA00583866 -10- EFTA00583867

uch investment, together with any and all dividends, payments, distributions, securities or other items of value at any time distributed or paid by ResearchGate to the Gates Purchaser in respect of such investment shall be referred to herein as the "ResearchGate Investment"). At any time and from time to t

invested in or know; Breakthrough Life Sciences Prize recipients; DST technology investment team, and; entities associated with our anchor investor Bill Gates, such as Bill Gates Ventures and the Bill and Melinda Gates Foundation. We are in the process of entering into an agreement with illumine, the leadi

, Lilly Ventures and Schrodinger (9.5%). Research Gate ResearchCate is developing a social networking site for the research scientist community. At ResearchGate. more than 3.5 million researchers already share and curate their data and results. The site has been described as a mashup of -Facebook, Twitter a